PMGC Holdings Inc. (NASDAQ:ELAB) Short Interest Down 52.0% in January

PMGC Holdings Inc. (NASDAQ:ELAB) was the recipient of a large decrease in short interest in the month of January. As of January 15th, there was short interest totaling 39,049 shares, a decrease of 52.0% from the December 31st total of 81,359 shares. Based on an average daily volume of 1,203,127 shares, the short-interest ratio is currently 0.0 days. Currently, 7.8% of the company’s stock are short sold. Currently, 7.8% of the company’s stock are short sold. Based on an average daily volume of 1,203,127 shares, the short-interest ratio is currently 0.0 days.

PMGC Stock Performance

Shares of NASDAQ ELAB traded up $0.18 during midday trading on Friday, reaching $3.51. 750,063 shares of the company’s stock were exchanged, compared to its average volume of 714,610. PMGC has a 52-week low of $3.03 and a 52-week high of $189.14. The business’s fifty day moving average price is $9.83 and its two-hundred day moving average price is $19.54. The stock has a market capitalization of $1.76 million, a PE ratio of -0.05 and a beta of 0.67.

PMGC (NASDAQ:ELAB) last issued its quarterly earnings data on Friday, November 14th. The company reported ($19.80) earnings per share for the quarter. The business had revenue of $0.29 million during the quarter.

Wall Street Analysts Forecast Growth

ELAB has been the topic of a number of recent research reports. Weiss Ratings restated a “sell (e+)” rating on shares of PMGC in a research note on Monday, December 29th. Wall Street Zen upgraded PMGC to a “sell” rating in a report on Saturday, October 25th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, PMGC currently has an average rating of “Sell”.

PMGC Company Profile

Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021. Elevai Labs, Inc was incorporated in 2020 and is based in Newport Beach, California.